Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
A new study used deep-learning AI to help uncover how the brain's evolution differed over the past 320 million years in ...
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
“Baylen Out Loud” is back with season 1, episode 7 today, Monday, Feb. 24, at 9 p.m. Eastern on TLC. If you cut ties with ...
There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy ...
In the third episode of The Deep End, Jon shares how DBS surgery went and how he and other volunteers felt in the days and weeks afterward.
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback